Neutrophil-to-Lymphocyte Ratio as a Factor Predicting Radiotherapy Induced Oral Mucositis in Head Neck Cancer Patients Treated with Radiotherapy

被引:17
|
作者
Homa-Mlak, Iwona [1 ]
Brzozowska, Anna [2 ]
Mlak, Radoslaw [1 ]
Szudy-Szczyrek, Aneta [3 ]
Malecka-Massalska, Teresa [1 ]
机构
[1] Med Univ Lublin, Dept Human Physiol, Radziwillowska 11, PL-20080 Lublin, Poland
[2] Med Univ Lublin, Dept Oncol, Jaczewskiego 7, PL-20090 Lublin, Poland
[3] Med Univ Lublin, Dept Hematooncol & Bone Marrow Transplantat, PL-20081 Lublin, Poland
关键词
oral mucositis; survival; radiotherapy; head and neck cancer; neutrophil-to-lymphocyte ratio; PRETREATMENT NEUTROPHIL; CONCURRENT CHEMORADIOTHERAPY; PROGNOSTIC-SIGNIFICANCE; SURVIVAL; CARCINOMA; OUTCOMES; THERAPY; TUMOR; TRANSPLANTATION; CHEMOTHERAPY;
D O I
10.3390/jcm10194444
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The objective of this research conducted in head and neck cancer (HNC) patients was the assessment of the relationship between neutrophil-to-lymphocyte ratio (NLR) and the incidence of severe radiotherapy (RT) induced oral mucositis (OM), as well as overall survival (OS). Methods: The study involved 207 patients in advanced stages (III-IV) of HNC. RTOG/EORTC scale was used to assess OM. The pre-treatment NLR was specified as the absolute neutrophil count divided by the absolute lymphocyte count. Results: Starting from second to seventh week of RT, we observed a significant, positive correlation between NLR values and OM grade. From the second to seventh week of RT, higher NLR values were related with significant increases (from 2- to over 24-fold) in the risk of occurrence of more severe OM (multivariate analysis confirmed its independent influence). Moreover, multivariate analysis for survival revealed that both higher TNM stage (HR = 1.84; p = 0.0043) and higher NLR values (HR = 1.48; p = 0.0395) were independent prognostic factors. Conclusion: NLR is a simple and accurate parameter that is useful in the evaluation of the risk of more severe OM, as well as an independent prognostic factor of OS in patients subjected to RT due to HNC.
引用
收藏
页数:15
相关论文
共 50 条
  • [21] PHENYLBUTYRATE MOUTHWASH MITIGATES ORAL MUCOSITIS DURING RADIOTHERAPY OR CHEMORADIOTHERAPY IN PATIENTS WITH HEAD-AND-NECK CANCER
    Yen, Sang-Hue
    Wang, Ling-Wei
    Lin, Yi-Hsien
    Jen, Yee-Min
    Chung, Yih-Lin
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (04): : 1463 - 1470
  • [22] Prognostic value of neutrophil-to-lymphocyte ratio in older patients with head and neck cancer
    Ku, Ja Yoon
    Roh, Jong-Lyel
    Kim, Sung-Bae
    Choi, Seung-Ho
    Nam, Soon Yuhl
    Kim, Sang Yoon
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (03) : 417 - 422
  • [23] Use of laser for the prevention and treatment of oral mucositis induced by radiotherapy and chemotherapy for head and neck cancer
    Munoz-Corcuera, Marta
    Gonzalez-Nieto, Almudena
    Lopez-Pintor Munoz, Rosa Maria
    MEDICINA CLINICA, 2014, 143 (04): : 170 - 175
  • [24] Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation
    Bojaxhiu, Beat
    Templeton, Arnoud J.
    Elicin, Olgun
    Shelan, Mohamed
    Zaugg, Kathrin
    Walser, Marc
    Giger, Roland
    Aebersold, Daniel M.
    Dal Pra, Alan
    RADIATION ONCOLOGY, 2018, 13
  • [25] Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer
    Vesty, Anna
    Gear, Kim
    Biswas, Kristi
    Mackenzie, Brett Wagner
    Taylor, Michael W.
    Douglas, Richard G.
    SUPPORTIVE CARE IN CANCER, 2020, 28 (06) : 2683 - 2691
  • [26] Oral microbial influences on oral mucositis during radiotherapy treatment of head and neck cancer
    Anna Vesty
    Kim Gear
    Kristi Biswas
    Brett Wagner Mackenzie
    Michael W. Taylor
    Richard G. Douglas
    Supportive Care in Cancer, 2020, 28 : 2683 - 2691
  • [27] RRM1 gene expression evaluated in the liquid biopsy (blood cfRNA) as a non-invasive, predictive factor for radiotherapy-induced oral mucositis and potential prognostic biomarker in head and neck cancer patients
    Mlak, Radoslaw
    Powrozek, Tomasz
    Brzozowska, Anna
    Homa-Mlak, Iwona
    Mazurek, Marcin
    Malecka-Massalska, Teresa
    CANCER BIOMARKERS, 2018, 22 (04) : 657 - 667
  • [28] Neutrophil-to-lymphocyte ratio as a prognostic marker for head and neck cancer with lung metastasis: a retrospective study
    Yanni, Antoine
    Buset, Thibaut
    Bouland, Cyril
    Loeb, Isabelle
    Lechien, Jerome R.
    Rodriguez, Alexandra
    Journe, Fabrice
    Saussez, Sven
    Dequanter, Didier
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2022, 279 (08) : 4103 - 4111
  • [29] Mucositis in head and neck cancer patients treated with radiotherapy and systemic therapies: Literature review and consensus statements.
    De Sanctis, Vitaliana
    Bossi, Paolo
    Sanguineti, Giuseppe
    Trippa, Fabio
    Ferrari, Daris
    Bacigalupo, Almalina
    Ripamonti, Carla Ida
    Buglione, Michela
    Pergolizzi, Stefano
    Langendjik, Johannes A.
    Murphy, Barbara
    Raber-Durlacher, Judith
    Russi, Elvio G.
    Lalla, Rajesh V.
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 100 : 147 - 166
  • [30] The effect of granulocyte colony-stimulating factor on oral mucositis in head and neck cancer patients treated with hyperfractionated radiotherapy
    Mascarin, M
    Franchin, G
    Minatel, E
    Gobitti, C
    Talamini, R
    De Maria, D
    Trovò, MG
    ORAL ONCOLOGY, 1999, 35 (02) : 203 - 208